530 related articles for article (PubMed ID: 11545734)
1. Regulation of PTEN transcription by p53.
Stambolic V; MacPherson D; Sas D; Lin Y; Snow B; Jang Y; Benchimol S; Mak TW
Mol Cell; 2001 Aug; 8(2):317-25. PubMed ID: 11545734
[TBL] [Abstract][Full Text] [Related]
2. Phosphorylation of human p53 at serine 46 determines promoter selection and whether apoptosis is attenuated or amplified.
Mayo LD; Seo YR; Jackson MW; Smith ML; Rivera Guzman J; Korgaonkar CK; Donner DB
J Biol Chem; 2005 Jul; 280(28):25953-9. PubMed ID: 15843377
[TBL] [Abstract][Full Text] [Related]
3. PTEN tumor suppressor regulates p53 protein levels and activity through phosphatase-dependent and -independent mechanisms.
Freeman DJ; Li AG; Wei G; Li HH; Kertesz N; Lesche R; Whale AD; Martinez-Diaz H; Rozengurt N; Cardiff RD; Liu X; Wu H
Cancer Cell; 2003 Feb; 3(2):117-30. PubMed ID: 12620407
[TBL] [Abstract][Full Text] [Related]
4. Hepatitis B Virus X protein modulates the expression of PTEN by inhibiting the function of p53, a transcriptional activator in liver cells.
Chung TW; Lee YC; Ko JH; Kim CH
Cancer Res; 2003 Jul; 63(13):3453-8. PubMed ID: 12839924
[TBL] [Abstract][Full Text] [Related]
5. PTEN protects p53 from Mdm2 and sensitizes cancer cells to chemotherapy.
Mayo LD; Dixon JE; Durden DL; Tonks NK; Donner DB
J Biol Chem; 2002 Feb; 277(7):5484-9. PubMed ID: 11729185
[TBL] [Abstract][Full Text] [Related]
6. Negative regulation of PKB/Akt-dependent cell survival by the tumor suppressor PTEN.
Stambolic V; Suzuki A; de la Pompa JL; Brothers GM; Mirtsos C; Sasaki T; Ruland J; Penninger JM; Siderovski DP; Mak TW
Cell; 1998 Oct; 95(1):29-39. PubMed ID: 9778245
[TBL] [Abstract][Full Text] [Related]
7. PTEN reverses MDM2-mediated chemotherapy resistance by interacting with p53 in acute lymphoblastic leukemia cells.
Zhou M; Gu L; Findley HW; Jiang R; Woods WG
Cancer Res; 2003 Oct; 63(19):6357-62. PubMed ID: 14559824
[TBL] [Abstract][Full Text] [Related]
8. Regulation of the insulin-like developmental pathway of Caenorhabditis elegans by a homolog of the PTEN tumor suppressor gene.
Gil EB; Malone Link E; Liu LX; Johnson CD; Lees JA
Proc Natl Acad Sci U S A; 1999 Mar; 96(6):2925-30. PubMed ID: 10077613
[TBL] [Abstract][Full Text] [Related]
9. PTEN mutation and epidermal growth factor receptor activation regulate vascular endothelial growth factor (VEGF) mRNA expression in human glioblastoma cells by transactivating the proximal VEGF promoter.
Pore N; Liu S; Haas-Kogan DA; O'Rourke DM; Maity A
Cancer Res; 2003 Jan; 63(1):236-41. PubMed ID: 12517803
[TBL] [Abstract][Full Text] [Related]
10. PTEN represses RNA Polymerase I transcription by disrupting the SL1 complex.
Zhang C; Comai L; Johnson DL
Mol Cell Biol; 2005 Aug; 25(16):6899-911. PubMed ID: 16055704
[TBL] [Abstract][Full Text] [Related]
11. Activation of Akt/protein kinase B overcomes a G(2)/m cell cycle checkpoint induced by DNA damage.
Kandel ES; Skeen J; Majewski N; Di Cristofano A; Pandolfi PP; Feliciano CS; Gartel A; Hay N
Mol Cell Biol; 2002 Nov; 22(22):7831-41. PubMed ID: 12391152
[TBL] [Abstract][Full Text] [Related]
12. Loss of tumor suppressor p53 decreases PTEN expression and enhances signaling pathways leading to activation of activator protein 1 and nuclear factor kappaB induced by UV radiation.
Wang J; Ouyang W; Li J; Wei L; Ma Q; Zhang Z; Tong Q; He J; Huang C
Cancer Res; 2005 Aug; 65(15):6601-11. PubMed ID: 16061640
[TBL] [Abstract][Full Text] [Related]
13. High cancer susceptibility and embryonic lethality associated with mutation of the PTEN tumor suppressor gene in mice.
Suzuki A; de la Pompa JL; Stambolic V; Elia AJ; Sasaki T; del Barco Barrantes I; Ho A; Wakeham A; Itie A; Khoo W; Fukumoto M; Mak TW
Curr Biol; 1998 Oct; 8(21):1169-78. PubMed ID: 9799734
[TBL] [Abstract][Full Text] [Related]
14. PTEN and p53: who will get the upper hand?
Trotman LC; Pandolfi PP
Cancer Cell; 2003 Feb; 3(2):97-9. PubMed ID: 12620402
[No Abstract] [Full Text] [Related]
15. p21/CDKN1A mediates negative regulation of transcription by p53.
Löhr K; Möritz C; Contente A; Dobbelstein M
J Biol Chem; 2003 Aug; 278(35):32507-16. PubMed ID: 12748190
[TBL] [Abstract][Full Text] [Related]
16. Genetic interactions between Pten and p53 in radiation-induced lymphoma development.
Mao JH; Wu D; Perez-Losada J; Nagase H; DelRosario R; Balmain A
Oncogene; 2003 Nov; 22(52):8379-85. PubMed ID: 14627978
[TBL] [Abstract][Full Text] [Related]
17. Promoter analysis of tumor suppressor gene PTEN: identification of minimum promoter region.
Sheng X; Koul D; Liu JL; Liu TJ; Yung WK
Biochem Biophys Res Commun; 2002 Mar; 292(2):422-6. PubMed ID: 11906179
[TBL] [Abstract][Full Text] [Related]
18. Dysregulated PTEN-PKB and negative receptor status in human breast cancer.
Shi W; Zhang X; Pintilie M; Ma N; Miller N; Banerjee D; Tsao MS; Mak T; Fyles A; Liu FF
Int J Cancer; 2003 Mar; 104(2):195-203. PubMed ID: 12569575
[TBL] [Abstract][Full Text] [Related]
19. Targeting mutants of PTEN reveal distinct subsets of tumour suppressor functions.
Leslie NR; Bennett D; Gray A; Pass I; Hoang-Xuan K; Downes CP
Biochem J; 2001 Jul; 357(Pt 2):427-35. PubMed ID: 11439092
[TBL] [Abstract][Full Text] [Related]
20. p53 regulates cell survival by inhibiting PIK3CA in squamous cell carcinomas.
Singh B; Reddy PG; Goberdhan A; Walsh C; Dao S; Ngai I; Chou TC; O-Charoenrat P; Levine AJ; Rao PH; Stoffel A
Genes Dev; 2002 Apr; 16(8):984-93. PubMed ID: 11959846
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
